PAX–FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features

肺泡横纹肌肉瘤 医学 病态的 横纹肌肉瘤 总体生存率 肿瘤科 内科学 儿科 病理 肉瘤
作者
Thomas Raze,Eve Lapouble,Brigitte Lacour,Sandra Guissou,Anne Sophie Defachelles,Nathalie Gaspar,Olivier Delattre,Gaëlle Pierron,Emmanuel Désandes
出处
期刊:Pediatric Blood & Cancer [Wiley]
卷期号:70 (4): e30228-e30228 被引量:20
标识
DOI:10.1002/pbc.30228
摘要

Abstract Background Alveolar rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer and cases with fusion PAX3–FOXO1 and PAX7–FOXO1 seem to have a poor prognosis. The aim is to evaluate whether PAX–FOXO1 alterations influence clinical outcome in childhood and adolescence population with ARMS. Procedure A population‐based study was conducted between 2011 and 2016 in patients less than 17 years with a diagnosis of ARMS. Overall survival (OS) depending on fusion status with clinical factors was analyzed. Results Out of 111 ARMS patients recorded in the French National Childhood Cancer Registry during the 2011–2016 period, 61% expressed PAX3–FOXO1, 15% expressed PAX7–FOXO1, 13% were FOXO1 fusion‐positive without PAX specification, and 7% were PAX–FOXO1 negative ( n = 4 missing data). Compared to patients with PAX7–FOXO1 positive ARMS, those with PAX3–FOXO1 positive tumor were significantly older (10–17 years: 57.4% vs. 29.4%), and had more often a metastatic disease (54.4% vs. 23.5%). Poorer 5‐year OS for patients with PAX3–FOXO1 and PAX not specified FOXO1‐positive tumor were observed (44.0% [32.0–55.4] and 35.7% [13.1–59.4], respectively). After adjustment for stage at diagnosis, patients with positive tumor for PAX3–FOXO1 were 3.6‐fold more likely to die than those with positive tumor for PAX7–FOXO1. Conclusion At the population level, PAX3–FOXO1 was associated with a significant higher risk of death compared to PAX7–FOXO1‐positive and PAX–FOXO1‐negative tumors, and could explain poorer 5‐year OS observed in adolescence population diagnosed with ARMS. A continuous risk score derived from the combination of clinical parameters with PAX3–FOXO1 fusion status represents a robust approach to improving current risk‐adapted therapy for ARMS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1234驳回了ZIYE的应助
1秒前
1秒前
科研通AI6.2的应助被lsl采纳,获得10
1秒前
1秒前
888的应助被道友且慢采纳,获得20
2秒前
Jun的应助被自然代亦采纳,获得10
2秒前
lwj发布了新的文献求助30
2秒前
寻一洲发布了新的文献求助10
2秒前
Finny发布了新的文献求助30
2秒前
2秒前
万能图书馆的应助被Jindyla采纳,获得10
2秒前
Orange的应助被reguxingshi采纳,获得10
3秒前
3秒前
3秒前
在水一方的应助被肖鹏采纳,获得10
4秒前
4秒前
务实大雁给务实大雁的求助进行了留言
4秒前
li完成签到 ,获得积分10
4秒前
聪慧的鸣凤完成签到 ,获得积分10
5秒前
宋宋完成签到,获得积分10
6秒前
6秒前
耿耿完成签到 ,获得积分10
6秒前
YanYingHaoComeon完成签到,获得积分10
6秒前
6秒前
思怡发布了新的文献求助10
6秒前
maguodrgon发布了新的文献求助10
7秒前
rengar完成签到,获得积分0
7秒前
wujingshuai发布了新的文献求助10
7秒前
笙兮完成签到 ,获得积分10
7秒前
7秒前
曲奇饼干发布了新的文献求助10
7秒前
aaa完成签到,获得积分10
8秒前
李明泰完成签到,获得积分20
8秒前
朱朱朱朱发布了新的文献求助20
8秒前
时若完成签到,获得积分10
8秒前
玉雁同学完成签到,获得积分10
8秒前
8秒前
8秒前
DU发布了新的文献求助30
9秒前
碎觉觉发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8174225
求助须知:如何正确求助?哪些是违规求助? 9566274
关于积分的说明 21785725
捐赠科研通 7768401
什么是DOI,文献DOI怎么找? 3431698
关于科研通互助平台的介绍 2555912
邀请新用户注册赠送积分活动 2477007